13F Pro13F Pro

Seven Fleet Capital Management LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 2092021
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare99.8%$604.8M
  • Other0.2%$1.1M

AUM History

13fpro.ai/research/fund/seven-fleet-capital-management-lp-2092021

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/seven-fleet-capital-management-lp-2092021

Seven Fleet Capital Management LP 13F holdings — Q2 2026

$605.9M portfolio (+92.3% QoQ) · 96 holdings · Q2 2026 13F · top 10 are 65% of the stock portfolio

All holdings — Seven Fleet Capital Management LP (Q2 2026)

96 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
IPSC$IPSCCentury Therapeutics, Inc.$10.7M+47%
CYTK$CYTKCYTOKINETICS INC$10.1M+93%
TSHA$TSHATaysha Gene Therapies, Inc.$9.9M+140%
MANE$MANEVeradermics, Inc$9.8MNew
AVBP$AVBPArriVent BioPharma, Inc.$8.6M+391%
TARS$TARSTarsus Pharmaceuticals, Inc.$7.9M+491%
XNCR$XNCRXencor Inc$7.8M+360%
ROIV$ROIVRoivant Sciences Ltd.$7.8M+72%
DMRA$DMRADamora Therapeutics, Inc.$7.4M+181%
AXSM$AXSMAxsome Therapeutics, Inc.$7.1M+105%
DFTX$DFTXDefinium Therapeutics, Inc.$7.0M+49%
DNTH$DNTHDianthus Therapeutics, Inc. /DE/$6.3M+19%
COGT$COGTCogent Biosciences, Inc.$5.7M-1%
ERAS$ERASErasca, Inc.$5.6M+38%
PTGX$PTGXProtagonist Therapeutics, Inc$5.6M+1035%

What changed in Q2 2026

Against the previous quarter's 13F: 23 new, 43 added to, 23 trimmed, 41 sold out. Share-count changes; largest moves by dollar size first.

New positions (23)

  • MIRM$MIRMMirum Pharmaceuticals, Inc.$12.9M

    first bought this quarter

  • MANE$MANEVeradermics, Inc$9.8M

    first bought this quarter

  • EDIT$EDITEditas Medicine, Inc.$4.3M

    first bought this quarter

  • STRO$STROSUTRO BIOPHARMA, INC.$3.8M

    first bought this quarter

  • SGMT$SGMTSagimet Biosciences Inc.$3.1M

    first bought this quarter

  • PRAX$PRAXPraxis Precision Medicines, Inc.$2.5M

    first bought this quarter

+17 more in the Excel export

Added to (43)

  • CGON$CGONCG Oncology, Inc.+2390%

    now $134.0M · held 3+ qtrs

  • TNGX$TNGXTango Therapeutics, Inc.+543%

    now $95.7M · held 3+ qtrs, 2 adds in a row

  • RVMD$RVMDRevolution Medicines, Inc.+200%

    now $45.3M · held 3+ qtrs, 2 adds in a row

  • PHVS$PHVSPharvaris N.V.+348%

    now $26.8M · held 3+ qtrs, 2 adds in a row

  • ASMB$ASMBASSEMBLY BIOSCIENCES, INC.+671%

    now $11.9M · held 3+ qtrs, 2 adds in a row

  • AVTX$AVTXAvalo Therapeutics, Inc.+260%

    now $14.2M · held 3+ qtrs, 2 adds in a row

+37 more in the Excel export

Trimmed (23)

  • AGIO$AGIOAGIOS PHARMACEUTICALS, INC.-73%

    now $2.1M · held 3+ qtrs

  • PCVX$PCVXVaxcyte, Inc.-73%

    now $1.8M · held 3+ qtrs

  • IDYA$IDYAIDEAYA Biosciences, Inc.-56%

    now $1.4M · held 2 qtrs

  • RLAY$RLAYRelay Therapeutics, Inc.-31%

    now $3.3M · held 3+ qtrs

  • SLN$SLNSilence Therapeutics plc-62%

    now $660K · held 3+ qtrs

  • KRYS$KRYSKrystal Biotech, Inc.-59%

    now $659K · held 3+ qtrs

+17 more in the Excel export

Sold out (41)

  • CG ONCOLOGY INCwas $97.4M
  • TYRA$TYRATyra Biosciences, Inc.was $7.5M

    held 2+ qtrs

  • TANGO THERAPEUTICS INCwas $6.3M
  • AVALO THERAPEUTICS INCwas $5.4M
  • MINERVA NEUROSCIENCES INCwas $5.4M
  • PHARVARIS N Vwas $4.1M

+35 more in the Excel export

Firm AUM (Form ADV): $434.6M as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Seven Fleet Capital Management LP has filed, 2 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Seven Fleet Capital Management?

Q2 2026 13F filed with the SEC on Aug 17, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Seven Fleet Capital Management's top 20 holdings: 29/100 (our AI quality score, weighted by position size; 12 of the 20 are scored)

Top 10 since filing

-20.8%

Value-weighted move of the 10 largest stock positions

Turnover

39%

Last quarter

Top 10 weight

65%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

0%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Seven Fleet Capital Management LP disclosed 96 positions worth $605.9M in its Form 13F-HR for Q2 2026, led by $CGON (CG Oncology, Inc.) at 22.1% of the equity portfolio, followed by $TNGX and $RVMD. During the quarter the fund opened 23 new positions and exited 41 — including a new stake in $MIRM. The portfolio is most concentrated in Healthcare (99.8% of disclosed assets). All figures are sourced directly from Seven Fleet Capital Management LP’s Form 13F-HR filing with the SEC under CIK 2092021.

Funds like this

managers whose biggest positions overlap Seven Fleet Capital Management's
TCG Crossover Management, LLC$4.16B 13F book · 14 shared top holdingsTNGXCGONABVXMIRMBoxer Capital Management, LLC$1.33B 13F book · 11 shared top holdingsTNGXRVMDABVXDFTXLogos Global Management LP$2.32B 13F book · 15 shared top holdingsRVMDTNGXCGONABVXFARALLON CAPITAL MANAGEMENT LLC$21.68B 13F book · 8 shared top holdingsRVMDLQDATNGXROIVRTW INVESTMENTS, LP$11.71B 13F book · 11 shared top holdingsCGONTNGXCYTKTARSSiren, L.L.C.$4.94B 13F book · 12 shared top holdingsTNGXRVMDELVNMANE

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Seven Fleet Capital Management LP

13F Pro is an AI hedge fund tracker and stock research platform. For Seven Fleet Capital Management LP (SEC CIK: 2092021), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Seven Fleet Capital Management LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.